Telomir Pharmaceuticals, Inc.
TELO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001971532
No open-market purchases or sales by Telomir Pharmaceuticals, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $3.80M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Telomir Pharmaceuticals, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −11 vs. Q2 2025
- Shares held
- 2.33M
- −475.7K (−16.9%) vs. Q2 2025
- Total value
- $3.24M
- −$268.9K (−7.7%) vs. Q2 2025
- New holders
- 6
- 6 more added
- Sold out
- 17
- 16 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TELO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $3.80M |
| Q1 2026 | 27 | $2.91M |
| Q4 2025 | 33 | $3.04M |
| Q3 2025 | 32 | $3.24M |
| Q2 2025 | 43 | $3.51M |
| Q1 2025 | 42 | $11.9M |
| Q4 2024 | 39 | $14.7M |
| Q3 2024 | 34 | $13.1M |
| Q2 2024 | 25 | $1.74M |
| Q1 2024 | 7 | $413.5K |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Telomir Pharmaceuticals, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,101,752 | $1.53M | 0.00% | −16,474−1.5% | Reduced |
| BlackRock, Inc. | 291,433 | $405.1K | 0.00% | −78,643−21.3% | Reduced |
| Millennium Management LLC | 222,404 | $309.1K | 0.00% | −25,295−10.2% | Reduced |
| Geode Capital Management, LLC | 196,030 | $272.6K | 0.00% | −850−0.4% | Reduced |
| Raymond James Financial Inc | 75,340 | $104.7K | 0.00% | +73,547+4,101.9% | Added |
| UBS Group AG | 63,536 | $88.3K | 0.00% | +14,805+30.4% | Added |
| State Street Corp | 58,600 | $81.5K | 0.00% | −3,000−4.9% | Reduced |
| Bank of New York Mellon Corp | 51,454 | $71.5K | 0.00% | +10.0% | Added |
| Suncoast Equity Management | 51,194 | $71.2K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 41,844 | $58.2K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 24,510 | $32.5K | 0.00% | +3,550+16.9% | Added |
| Resources Investment Advisors, LLC. | 23,000 | $32.0K | 0.00% | +9,000+64.3% | Added |
| Goldman Sachs Group Inc | 22,636 | $31.5K | 0.00% | −137,958−85.9% | Reduced |
| Praetorian Wealth Management, Inc. | 20,000 | $27.8K | 0.01% | +20,000 | New |
| Mariner, LLC | 19,994 | $27.8K | 0.00% | +19,994 | New |
| Jane Street Group, LLC | 19,775 | $27.5K | 0.00% | −29,781−60.1% | Reduced |
| Clearstead Advisors, LLC | 12,530 | $17.4K | 0.00% | +12,530 | New |
| Qube Research & Technologies Ltd | 11,015 | $15.3K | 0.00% | −15,494−58.4% | Reduced |
| Kestra Private Wealth Services, LLC | 11,000 | $15.3K | 0.00% | +11,000 | New |
| Regions Financial Corp | 10,638 | $14.8K | 0.00% | +10,638 | New |
| Tower Research Capital LLC (TRC) | 1,251 | $1.74K | 0.00% | −7,395−85.5% | Reduced |
| Royal Bank of Canada | 599 | $1.00K | 0.00% | −345−36.5% | Reduced |
| Jones Financial Companies LLLP | 600 | $834 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 379 | $527 | 0.00% | +333+723.9% | Added |
| BNP Paribas Arbitrage, SA | 347 | $482 | 0.00% | −914−72.5% | Reduced |
| Morgan Stanley | 334 | $464 | 0.00% | −25,073−98.7% | Reduced |
| Bank of America Corp | 23 | $32 | 0.00% | −7,420−99.7% | Reduced |
| SRS Capital Advisors, Inc. | 9 | $12 | 0.00% | +9 | New |
| SBI Securities Co., Ltd. | 4 | $6 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 2 | $3 | 0.00% | −3,015−99.9% | Reduced |
| Citigroup Inc | 1 | $1 | 0.00% | −2,074−100.0% | Reduced |
| CWM, LLC | 2 | $0 | 0.00% | −2,705−99.9% | Reduced |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −75,770−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −64,423−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −33,234−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −28,889−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −23,817−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −22,911−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −16,399−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −10,829−100.0% | Sold out |
| Tactive Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −5,605−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1,762−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −667−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −149−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −96−100.0% | Sold out |
| Essential Partners LLC | 0 | $0 | 0.00% | −63−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |